The S&P 500 wrapped up the worst quarter since the third quarter of 2022, plunging 4.6%, due to escalating trade tensions and concerns over stagflation. The Trump administration imposed tariffs on ...

Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to new research findings from the University of Toronto. Applying 25% trade ...

Increased usage among women and older adults during 2019-2023 seemed related more to falling prices than to the expanding ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The wave of U.S. tariffs and President Trump's 51st state threats have dramatically shifted marketing priorities for brands ...

Building on a storied history of engagement that supersedes partisan politics, there is no time to lose for Canada to strategically renew its role in global health.

Tariff turmoil has continued to provide intense volatility for the stock market, with certain sector seeing outsized losses ...

In a new survey, Canadians say they want stronger government support to improve access to physicians and reduce the burden of ...

Ariel's international strategies led their respective primary benchmarks for 2024 full year. Click here to read the full ...

Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...

With a well-established reputation for excellence in the manufacturing and distribution of control valves and related instruments, CVS Controls is uniquely positioned to represent and distribute ...

Investors are optimistic that the company can overcome its difficulties following last year’s 40% drop in its stock price, ...